BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Venturini E, Turkova A, Chiappini E, Galli L, de Martino M, Thorne C. Tuberculosis and HIV co-infection in children. BMC Infect Dis 2014;14 Suppl 1:S5. [PMID: 24564453 DOI: 10.1186/1471-2334-14-S1-S5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 46] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Banada PP, Naidoo U, Deshpande S, Karim F, Flynn JL, O'Malley M, Jones M, Nanassy O, Jeena P, Alland D. A Novel Sample Processing Method for Rapid Detection of Tuberculosis in the Stool of Pediatric Patients Using the Xpert MTB/RIF Assay. PLoS One 2016;11:e0151980. [PMID: 27007974 DOI: 10.1371/journal.pone.0151980] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
2 Ohene SA, Fordah S, Dela Boni P. Childhood tuberculosis and treatment outcomes in Accra: a retrospective analysis. BMC Infect Dis 2019;19:749. [PMID: 31455234 DOI: 10.1186/s12879-019-4392-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
3 Acharya S, Palkar A, Sayed AP, Setia MS. Retrospective cohort analysis of survival of children living with HIV/AIDS in Mumbai, India. BMJ Open 2021;11:e050534. [PMID: 34518268 DOI: 10.1136/bmjopen-2021-050534] [Reference Citation Analysis]
4 Buya AB, Witika BA, Bapolisi AM, Mwila C, Mukubwa GK, Memvanga PB, Makoni PA, Nkanga CI. Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review. Pharmaceutics 2021;13:2041. [PMID: 34959323 DOI: 10.3390/pharmaceutics13122041] [Reference Citation Analysis]
5 Moolasart V, Chottanapund S, Ausavapipit J, Likanonsakul S, Uttayamakul S, Changsom D, Lerdsamran H, Puthavathana P. The Effect of Detectable HIV Viral Load among HIV-Infected Children during Antiretroviral Treatment: A Cross-Sectional Study. Children (Basel) 2018;5:E6. [PMID: 29301267 DOI: 10.3390/children5010006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
6 de Souza Pereira JJ, Pereira AP, Jandú JJ, da Paz JA, Crovella S, Dos Santos Correia MT, de Azevêdo Silva J. Commiphora leptophloeos Phytochemical and Antimicrobial Characterization. Front Microbiol 2017;8:52. [PMID: 28174564 DOI: 10.3389/fmicb.2017.00052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
7 Wang M, Gauthier A, Daley L, Dial K, Wu J, Woo J, Lin M, Ashby C, Mantell LL. The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases. Antioxid Redox Signal 2019;31:954-93. [PMID: 31184204 DOI: 10.1089/ars.2019.7818] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
8 Chabala C, Turkova A, Thomason MJ, Wobudeya E, Hissar S, Mave V, van der Zalm M, Palmer M, Kapasa M, Bhavani PK, Balaji S, Raichur PA, Demers AM, Hoddinott G, Owen-Powell E, Kinikar A, Musoke P, Mulenga V, Aarnoutse R, McIlleron H, Hesseling A, Crook AM, Cotton M, Gibb DM; SHINE trial team. Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial. Trials 2018;19:237. [PMID: 29673395 DOI: 10.1186/s13063-018-2608-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
9 Comberiati P, Di Cicco M, Paravati F, Pelosi U, Di Gangi A, Arasi S, Barni S, Caimmi D, Mastrorilli C, Licari A, Chiera F. The Role of Gut and Lung Microbiota in Susceptibility to Tuberculosis. Int J Environ Res Public Health 2021;18:12220. [PMID: 34831976 DOI: 10.3390/ijerph182212220] [Reference Citation Analysis]
10 Fauci AS, Eisinger RW. Reimagining the Research Approach to Tuberculosis. Am J Trop Med Hyg 2018;98:650-2. [PMID: 29363452 DOI: 10.4269/ajtmh.17-0999] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
11 Otiende VA, Achia TN, Mwambi HG. Bayesian hierarchical modeling of joint spatiotemporal risk patterns for Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) in Kenya. PLoS One 2020;15:e0234456. [PMID: 32614847 DOI: 10.1371/journal.pone.0234456] [Reference Citation Analysis]
12 Soriano-Arandes A, Brugueras S, Rodríguez Chitiva A, Noguera-Julian A, Orcau À, Martín-Nalda A, Millet JP, Vallmanya T, Méndez M, Coll-Sibina M, Mayol L, Clopés A, Pineda V, García L, López N, Calavia O, Rius N, Pérez-Porcuna TM, Soler-Palacín P, Caylà JA. Clinical Presentations and Outcomes Related to Tuberculosis in Children Younger Than 2 Years of Age in Catalonia. Front Pediatr 2019;7:238. [PMID: 31245340 DOI: 10.3389/fped.2019.00238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Anígilájé EA, Aderibigbe SA, Adeoti AO, Nweke NO. Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors? PLoS One 2016;11:e0156177. [PMID: 27232185 DOI: 10.1371/journal.pone.0156177] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
14 Jacobs TG, Svensson EM, Musiime V, Rojo P, Dooley KE, McIlleron H, Aarnoutse RE, Burger DM, Turkova A, Colbers A; WHO Paediatric Antiretroviral Working Group. Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review. J Antimicrob Chemother 2020;75:3433-57. [PMID: 32785712 DOI: 10.1093/jac/dkaa328] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 McLigeyo A, Wekesa P, Owuor K, Mwangi J, Isavwa L, Mutysia I. Factors associated with treatment outcomes among children and adolescents living with HIIV receiving antiretroviral therapy in central Kenya. AIDS Res Hum Retroviruses 2022. [PMID: 35229643 DOI: 10.1089/AID.2021.0112] [Reference Citation Analysis]
16 Salvadori N, Ngo-Giang-Huong N, Duclercq C, Kanjanavanit S, Ngampiyaskul C, Techakunakorn P, Puangsombat A, Figoni J, Mary JY, Collins IJ, Cressey TR, Le Cœur S, Sirirungsi W, Lallemant M, McIntosh K, Jourdain G. Incidence of Tuberculosis and Associated Mortality in a Cohort of Human Immunodeficiency Virus-Infected Children Initiating Antiretroviral Therapy. J Pediatric Infect Dis Soc 2017;6:161-7. [PMID: 28204517 DOI: 10.1093/jpids/piw090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Zhang Q, Frange P, Blanche S, Casanova JL. Pathogenesis of infections in HIV-infected individuals: insights from primary immunodeficiencies. Curr Opin Immunol 2017;48:122-33. [PMID: 28992464 DOI: 10.1016/j.coi.2017.09.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
18 Choudhary RK, Wall KM, Njuguna I, Pavlinac PB, LaCourse SM, Otieno V, Gatimu J, Stern J, Maleche-Obimbo E, Wamalwa D, John-Stewart G, Cranmer LM. Monocyte-to-Lymphocyte Ratio Is Associated With Tuberculosis Disease and Declines With Anti-TB Treatment in HIV-Infected Children. J Acquir Immune Defic Syndr 2019;80:174-81. [PMID: 30399036 DOI: 10.1097/QAI.0000000000001893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Gutiérrez-González LH, Juárez E, Carranza C, Carreto-Binaghi LE, Alejandre A, Cabello-Gutiérrrez C, Gonzalez Y. Immunological Aspects of Diagnosis and Management of Childhood Tuberculosis. Infect Drug Resist 2021;14:929-46. [PMID: 33727834 DOI: 10.2147/IDR.S295798] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Adeleke OA, Hayeshi RK, Davids H. Development and Evaluation of a Reconstitutable Dry Suspension Containing Isoniazid for Flexible Pediatric Dosing. Pharmaceutics 2020;12:E286. [PMID: 32210125 DOI: 10.3390/pharmaceutics12030286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Olbrich L, Stockdale L, Basu Roy R, Song R, Cicin-Sain L, Whittaker E, Prendergast AJ, Fletcher H, Seddon JA. Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward. PLoS Pathog 2021;17:e1010061. [PMID: 34882748 DOI: 10.1371/journal.ppat.1010061] [Reference Citation Analysis]
22 Belay GM, Wubneh CA. Childhood tuberculosis treatment outcome and its association with HIV co-infection in Ethiopia: a systematic review and meta-analysis. Trop Med Health 2020;48:7. [PMID: 32099521 DOI: 10.1186/s41182-020-00195-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Montales MT, Chaudhury A, Beebe A, Patil S, Patil N. HIV-Associated TB Syndemic: A Growing Clinical Challenge Worldwide. Front Public Health 2015;3:281. [PMID: 26779470 DOI: 10.3389/fpubh.2015.00281] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
24 Cardoso CAA, Rossoni AMO, Rezende JM, Aurilio RB, Santos RJFLD, Ferrarini MAG, Kritski AL, Martin A, Sant'Anna CC. String test: a potentially useful tool in the diagnosis of pulmonary tuberculosis in Brazilian children and adolescents. Rev Inst Med Trop Sao Paulo 2022;64:e27. [PMID: 35384958 DOI: 10.1590/S1678-9946202264027] [Reference Citation Analysis]
25 Fry SH, Barnabas SL, Cotton MF. Tuberculosis and HIV-An Update on the "Cursed Duet" in Children. Front Pediatr 2019;7:159. [PMID: 32211351 DOI: 10.3389/fped.2019.00159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Daniel OJ, Adejumo OA, Gidado M, Abdur-Razzaq HA, Jaiyesimi EO. HIV-TB co-infection in children: associated factors and access to HIV services in Lagos, Nigeria. Public Health Action 2015;5:165-9. [PMID: 26399285 DOI: 10.5588/pha.15.0027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
27 Ngugi SK, Muiruri P, Odero T, Gachuno O. Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study. BMC Infect Dis 2020;20:294. [PMID: 32664847 DOI: 10.1186/s12879-020-05011-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
28 Mukuku O, Mutombo AM, Kakisingi CN, Musung JM, Wembonyama SO, Luboya ON. Tuberculosis and HIV co-infection in Congolese children: risk factors of death. Pan Afr Med J 2019;33:326. [PMID: 31692828 DOI: 10.11604/pamj.2019.33.326.18911] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Maritz E, Schimana W. Koinfektionen mit humanem Immundefizienzvirus und Tuberkulose im Kindesalter. Monatsschr Kinderheilkd 2015;163:1130-7. [DOI: 10.1007/s00112-015-3377-9] [Reference Citation Analysis]
30 Dubois M, Faro EZ, Lee DS, Katin V, Kenkou K, Fiori KP. Integrating childhood TB: applying the care delivery value chain to improve pediatric HIV/TB services in Togo, West Africa. AIDS Care 2020;32:1445-50. [PMID: 32460525 DOI: 10.1080/09540121.2020.1770672] [Reference Citation Analysis]
31 Gupta RK, Lucas SB, Fielding KL, Lawn SD. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS 2015;29:1987-2002. [PMID: 26266773 DOI: 10.1097/QAD.0000000000000802] [Cited by in Crossref: 171] [Cited by in F6Publishing: 128] [Article Influence: 28.5] [Reference Citation Analysis]
32 LaCourse SM, Pavlinac PB, Cranmer LM, Njuguna IN, Mugo C, Gatimu J, Stern J, Walson JL, Maleche-Obimbo E, Oyugi J, Wamalwa D, John-Stewart G. Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children. AIDS 2018;32:69-78. [PMID: 29028662 DOI: 10.1097/QAD.0000000000001662] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
33 Riccardi N, Rotulo GA, Castagnola E. Definition of Opportunistic Infections in Immunocompromised Children on the Basis of Etiologies and Clinical Features: A Summary for Practical Purposes. Curr Pediatr Rev 2019;15:197-206. [PMID: 31242834 DOI: 10.2174/1573396315666190617151745] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
34 Wobudeya E, Sekadde-Kasirye M, Kimuli D, Mugabe F, Lukoye D. Trend and outcome of notified children with tuberculosis during 2011-2015 in Kampala, Uganda. BMC Public Health 2017;17:963. [PMID: 29258581 DOI: 10.1186/s12889-017-4988-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
35 Rossouw TM, Feucht UD, Melikian G, van Dyk G, Thomas W, du Plessis NM, Avenant T. Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa. PLoS One 2015;10:e0133452. [PMID: 26196688 DOI: 10.1371/journal.pone.0133452] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
36 Mu W, Bartlett AW, Bunupuradah T, Chokephaibulkit K, Kumarasamy N, Ly PS, Hansudewechakul R, Nguyen LV, Lumbiganon P, Sudjaritruk T, Mohamed TAJ, Yusoff NKN, Truong KH, Do VC, Fong MS, Nallusamy R, Kurniati N, Wati DK, Sohn AH, Kariminia A, Zhang F; TREAT Asia Pediatric HIV Observational Database of IeDEA Asia-Pacific. Early and Late Virologic Failure After Virologic Suppression in HIV-Infected Asian Children and Adolescents. J Acquir Immune Defic Syndr 2019;80:308-15. [PMID: 30531299 DOI: 10.1097/QAI.0000000000001921] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Shugaeva SN, Savilov ED. Prognostic Model for Progradient Tuberculosis Course in HIV-Infected Children. Sovrem Tekhnologii Med 2020;12:74-8. [PMID: 34513056 DOI: 10.17691/stm2020.12.2.09] [Reference Citation Analysis]
38 Snow KJ, Cruz AT, Seddon JA, Ferrand RA, Chiang SS, Hughes JA, Kampmann B, Graham SM, Dodd PJ, Houben RM, Denholm JT, Sawyer SM, Kranzer K. Adolescent tuberculosis. Lancet Child Adolesc Health 2020;4:68-79. [PMID: 31753806 DOI: 10.1016/S2352-4642(19)30337-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
39 Mbugi EV, Katale BZ, Lupindu AM, Keyyu JD, Kendall SL, Dockrell HM, Michel AL, Matee MI, van Helden PD. Tuberculosis Infection: Occurrence and Risk Factors in Presumptive Tuberculosis Patients of the Serengeti Ecosystem in Tanzania. East Afr Health Res J 2017;1:19-30. [PMID: 34308155 DOI: 10.24248/EAHRJ-D-16-00319] [Reference Citation Analysis]
40 Yin N, Delord M, Giovanni A, del Grande J, Drancourt M, Brouqui P, Lagier JC. Laryngeal tuberculosis diagnosed by stool sample cultures: a case report. J Med Case Rep 2015;9:74. [PMID: 25886183 DOI: 10.1186/s13256-015-0548-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
41 Tiruneh F, Deyas Y. How Far Does Highly Active Antiretroviral Treatment Reduce TB Incidence among Children? A Marginal Structural Modeling Analysis, Southwest Ethiopia. Ethiop J Health Sci 2020;30:653-60. [PMID: 33911825 DOI: 10.4314/ejhs.v30i5.3] [Reference Citation Analysis]
42 Motamedifar M, Ebrahim-Saraie HS, Abadi AR, Moghadam MN. First Outcome of MDR-TB among Co-Infected HIV/TB Patients from South-West Iran. Tuberc Respir Dis (Seoul) 2015;78:253-7. [PMID: 26175780 DOI: 10.4046/trd.2015.78.3.253] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
43 Hrapcak S, Bekele A, Ahmed J, Ayalew J, Gutreuter S, Kumssa H, Antefe T, Mengistu S, Mirkovic K, Dziuban EJ, Ross C, Belay Z, Tilahun T, Kassa D, Teferi W. Finding Children Living With HIV in Low-prevalence Countries: HIV Prevalence and Testing Yield From 5 Entry Points in Ethiopia. Pediatr Infect Dis J 2021;40:1090-5. [PMID: 34609102 DOI: 10.1097/INF.0000000000003324] [Reference Citation Analysis]
44 Naidoo J, Mahomed N, Moodley H. A systemic review of tuberculosis with HIV coinfection in children. Pediatr Radiol 2017;47:1269-76. [PMID: 29052773 DOI: 10.1007/s00247-017-3895-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
45 Rabie H, Frigati L, Hesseling AC, Garcia-Prats AJ. Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected children. J Int AIDS Soc 2015;18:20236. [PMID: 26639110 DOI: 10.7448/IAS.18.7.20236] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
46 Boisson-Dupuis S, Bustamante J, El-Baghdadi J, Camcioglu Y, Parvaneh N, El Azbaoui S, Agader A, Hassani A, El Hafidi N, Mrani NA, Jouhadi Z, Ailal F, Najib J, Reisli I, Zamani A, Yosunkaya S, Gulle-Girit S, Yildiran A, Cipe FE, Torun SH, Metin A, Atikan BY, Hatipoglu N, Aydogmus C, Kilic SS, Dogu F, Karaca N, Aksu G, Kutukculer N, Keser-Emiroglu M, Somer A, Tanir G, Aytekin C, Adimi P, Mahdaviani SA, Mamishi S, Bousfiha A, Sanal O, Mansouri D, Casanova JL, Abel L. Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev 2015;264:103-20. [PMID: 25703555 DOI: 10.1111/imr.12272] [Cited by in Crossref: 122] [Cited by in F6Publishing: 105] [Article Influence: 17.4] [Reference Citation Analysis]
47 Sütçü M, Acar M, Aktürk H, Hançerli Torun S, Beka H, Ağaçfidan A, Salman N, Somer A. Clinical Findings of Pediatric HIV Infection in a Tertiary Center in Turkey. Balkan Med J 2017;34:239-45. [PMID: 28443591 DOI: 10.4274/balkanmedj.2015.1571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
48 Jin HJ, Kang DY, Nam YH, Ye YM, Koh YI, Hur GY, Kim SH, Yang MS, Kim S, Jeong YY, Kim MH, Choi JH, Kang HR, Jo EJ, Park HK; Korean Severe Cutaneous Adverse Reactions Consortium (KoSCAR). Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients. Allergy Asthma Immunol Res 2021;13:245-55. [PMID: 33474859 DOI: 10.4168/aair.2021.13.2.245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Romero-Cordero S, Kirwan R, Noguera-Julian A, Cardellach F, Fortuny C, Morén C. A Mitocentric View of the Main Bacterial and Parasitic Infectious Diseases in the Pediatric Population. Int J Mol Sci 2021;22:3272. [PMID: 33806981 DOI: 10.3390/ijms22063272] [Reference Citation Analysis]
50 Gopalakrishnan V, Bose E, Nair U, Cheng Y, Ghebremichael M. Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection. BMC Infect Dis 2020;20:756. [PMID: 33059622 DOI: 10.1186/s12879-020-05458-w] [Reference Citation Analysis]
51 Tiruneh F, Deyas Y. Effect of highly active antiretroviral treatment on TB incidence among HIV infected children and their clinical profile, retrospective cohort study, South West Ethiopia. Sci Rep 2020;10:21468. [PMID: 33293656 DOI: 10.1038/s41598-020-78466-0] [Reference Citation Analysis]
52 Kamphee H, Chaiprasert A, Prammananan T, Wiriyachaiporn N, Kanchanatavee A, Dharakul T. Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay. PLoS One 2015;10:e0137791. [PMID: 26355296 DOI: 10.1371/journal.pone.0137791] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
53 Crook AM, Turkova A, Musiime V, Bwakura-Dangarembizi M, Bakeera-Kitaka S, Nahirya-Ntege P, Thomason M, Mugyenyi P, Musoke P, Kekitiinwa A, Munderi P, Nathoo K, Prendergast AJ, Walker AS, Gibb DM; ARROW Trial Team. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy. BMC Med 2016;14:50. [PMID: 27004529 DOI: 10.1186/s12916-016-0593-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
54 Atalell KA, Birhan Tebeje N, Ekubagewargies DT. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study. PLoS One 2018;13:e0197145. [PMID: 29787596 DOI: 10.1371/journal.pone.0197145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
55 Rabie H, Goussard P. Tuberculosis and pneumonia in HIV-infected children: an overview. Pneumonia (Nathan) 2016;8:19. [PMID: 28702298 DOI: 10.1186/s41479-016-0021-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
56 Chanie ES, Gelaye GA, Tadesse TY, Feleke DG, Admas WT, Molla Alemu E, Azanaw MM, Tiruneh SA, Gebremariam AD, Birhane BM, Bayih WA, Aragie G. Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study. PLoS One 2021;16:e0258964. [PMID: 34932563 DOI: 10.1371/journal.pone.0258964] [Reference Citation Analysis]